Cancer drugmaker Onyx Pharmaceuticals Inc said on Sunday it rejected a roughly $10 billion takeover offer from larger biotechnology company Amgen Inc as too low but still is considering selling itself. ...
via Business & Finance News - Yahoo! Finance http://finance.yahoo.com/news/onyx-explores-possible-sale-rejecting-001519769.html
via Business & Finance News - Yahoo! Finance http://finance.yahoo.com/news/onyx-explores-possible-sale-rejecting-001519769.html
0 commentaires:
Enregistrer un commentaire